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Análise da variabilidade da expressão genética em biofilmes de S. epidermidis 
 
RESUMO 
Staphylococcus epidermidis é um agente bacteriano comensal que coloniza, maioritariamente, o 
epitélio humano mas, mediante determinadas condições, pode tornar-se num agente patogénico 
oportunista. Atualmente, esta espécie é causadora da maior parte de infeções adquiridas em 
ambiente hospitalar, especificamente em dispositivos médicos. Os mecanismos de colonização e 
adaptação desta bactéria não estão totalmente estudados, no entanto é conhecido que esta 
bactéria torna-se patogénica quando o hospedeiro está imunodeprimido e o processo infecioso 
ocorre devido à inserção do dispositivo médico e, consequentemente, à formação de agregados 
tridimensionais denominados de biofilme. Os biofilmes fornecem inúmeras vantagens às bactérias 
nomeadamente, adaptação a novos ambientes, proteção física, resistência a antibióticos e 
mecanismos de defesa ao sistema imunitário do hospedeiro. Todas estas interações resultam de 
diferentes perfis de expressão genética e, desta forma, é extremamente importante o estudo das 
alterações na expressão dos genes, quando os biofilmes estão presentes. Para tal, são 
fundamentais três etapas experimentais: extração de RNA, síntese de cDNA e PCR quantitativo em 
tempo real. No entanto, sabe-se que há variabilidade inerente a cada uma das etapas, bem como 
relativo ao crescimento das estruturas heterogéneas dos próprios biofilmes. O principal objetivo 
deste trabalho foi estudar a influência das várias etapas experimentais na variabilidade na 
expressão genética no crescimento bacteriano. Ao longo deste trabalho, estudou-se a capacidade 
de formação de biofilme e a presença dos genes de interesse, entre diferentes estirpes de S. 
epidermidis. De seguida, selecionou-se as estirpes mais indicadas para a quantificação da 
expressão genética. Os nossos resultados demonstraram que a variabilidade biológica foi o 
principal causador da variabilidade na quantificação da expressão dos genes. Por conseguinte, 
propusemos a otimização de um simples protocolo experimental, de modo a minimizar esta 
variabilidade. Esta otimização baseou-se, na utilização de uma mistura de 20 biofilmes 
independentes, utilizados num único passo de extração de RNA. Foi observado, com sucesso, a 
redução da variabilidade biológica, utilizando duas estirpes independentes de S. epidermidis. 
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Analysis of gene expression variability in Staphylococcus epidermidis biofilms 
 
ABSTRACT 
S. epidermidis is the most frequently bacteria isolated from human epithelia, and for a long time, it 
has been regarded as an innocuous commensal bacterium. However, currently, this bacteria 
persist as a major cause of hospital and community-acquired infections. It is primarily associated 
with infections of indwelling medical devices, by the formation of a structure called a biofilm.  The 
biofilms can quickly adapt to new conditions and consequently, can result in the appearance of 
infections, that are resistance to many antibiotics and mechanisms of the host immune defense. 
So, it is crucial to study gene expression and their influence in biofilm formation. In gene 
expression studies, there are three fundamental experimental steps which have some variability: 
RNA extraction, reverse-transcriptase reaction and quantitative polymerase chain reaction (qPCR). 
However, since biofilms are very heterogeneous communities, often gene expression studies reveal 
a high variability.  The objective of this work was to demonstrate and understand the influence in 
the variability of gene expression quantification, by the individual experimental steps required for 
gene expression quantification, namely bacterial growth, RNA extraction, reverse transcriptase and 
real-time quantitative PCR. We tested the biofilm formation and the presence of key genes in 
several strains of S. epidermidis in order to select the strains to be used in the gene expression 
studies. Our results demonstrated that biologic variability was the step which more influence gene 
expression quantification. Additionally, we proposed an optimized protocol to enhance gene 
expression reproducibility in S. epidermidis biofilms and our results were favorable since we 
reduced the biologic variability with a pool of 20 biofilms, as determined by the quantification of 
gene expression in two independent strains. 
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1.1 Staphylococcus epidermidis 
Staphylococci is a group of bacteria that are responsible for causing a variety of diseases, 
ranging from minor skin infections to life-threatening bacteremia and may cause a significant 
morbidity and/or mortality (Gill, 2005; CDC, 2012). Currently, they persist as a major cause of 
hospital and community-acquired infections worldwide which represents an increasing problem in 
modern medicine (O´Gara, 2001). Nevertheless, some species of Staphylococci have a good 
symbiotic relationship with their host (Azevedo, 2012; Li, 2000; Baldassarri, 1997).  
 A major nosocomial and opportunistic pathogen of this genus is Staphylococcus 
epidermidis that belongs to the genus Staphylococcus, family Staphylococcaceae. This genus has 
leastwise 30 species whereupon Staphylococcus aureus, Staphylococcus epidermidis and 
Staphylococcus saprophyticus which are commonly associated with human infections (Azevedo, 
2012; Euzeby, 2014). 
 S. epidermidis is the most frequently isolated from human epithelia, and colonizes the 
axillae, head and nares (Kloos and Musselwhite, 1975) and for a long time, it has been regarded 
as an innocuous commensal bacterium (Vuong and Otto, 2002). Epidemiological studies have 
demonstrated that healthy people carry between 10 and 24 different strains of S. epidermidis at 
any one time (Kloos and Musselwhite, 1975).  This specie is a gram-positive (like all 
Staphylococcus) which means that the cell hall is constituted by a thick layer of peptidoglycan and 
is known as coagulase-negative staphylococci (CoNS), since it does not produce the coagulase 
enzyme (Wang, 2003; Wisplinghoff, 2003). In clinical microbiology, CoNS are used to distinguish 
between S. aureus (produces coagulase enzyme) and other staphylococci. However, based in 
some studies that did a species identification, it his proposed that most of non-specified CoNS 
infections are due to S. epidermidis (CDC, 2004; Rogers et al., 2009). 
 The cells of S. epidermidis are spherical, encapsulated and frequently, in the form of 
irregular curls. The colonies are smooth, high, shiny and opaque, varying it´s color from white to 
golden yellow (Götz et al., 2006). From a biochemical point of view, S. epidermidis is facultative 
anaerobic, which means that they can grow in the absence of oxygen or having aerobic respiration; 
catalase positive responsible for catalyze the decomposition of hydrogen peroxide to water and 
oxygen and oxidase negative which means that not produce cytochrome c oxidase (Götz et al., 
2006). This specie colonizes the skin of human population as previously mentioned (symbiotic 
relationship). Although the mechanisms of adaption and colonization are not fully understood, 
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analysis of S. epidermidis genome revealed the carriage of genes with predicted function in the 
protection (Gill et al., 2005; Zhang et al., 2003). This bacterium is primarily associated with 
infections of indwelling medical devices (pathogen relationship), such as prosthetic heart valves, 
peripheral or central intravenous catheters and joint prostheses (Dai et al., 2012). These infections 
occur during device insertion and form multilayered agglomerations called biofilms that will be 
further discussed below (Chu et al., 2009). 
 
1.2 Microbial biofilms  
The majority of bacteria (around 99%) are normally found in biofilm (O´Gara and 
Humphreys, 2001). It has been suggested that biofilms can provide many advantages to bacteria: 
adaptation at new environments, such as mutations in genome (Percival et al., 2000); physic 
protection by tridimensional biofilm and their matrix (Donlan and Costerton, 2002); metabolic 
potential (heterogeneity and stratification) that indicates different genetic expressions of 
microorganisms and source of genetic information that can be an advantage to evolution of species 
(Costerton et al., 1999). For the same reason, several reports demonstrated that pathogenic 
bacteria form biofilms preferentially, which is recognized as the major of virulence factor (O´Gara 
and Humphreys, 2001). These biofilms are extremely difficult to threat and represents a serious 
burden to the public health system (Chu et al., 2009). 
 
1.2.1 General model of biofilm formation 
A biofilm is normally defined as a structured and three-dimensional community of bacteria  
attached to an abiotic or living surface and surrounded by a matrix of extracellular polymeric 
substances (EPS) (Percival et al., 2012) such as proteins, lipids, polysaccharides, nucleic acids 
(Donlan and Costerton, 2002).  
Biofilm formation occurs in several stages: (1) contact of planktonic bacteria with a 
surface, mediated by non-specific interactions such as hydrophobic and electrostatic interactions; 
(2) growth in clusters with the presence of specific molecules, such as adhesins; (3) the matrix 
becomes to be formed; (4) biofilm maturation (more thicker) and the matrix more proeminent; (5) 
bacteria will then detach from the biofilm and (6) will colonize different surfaces or regions of a 
specific surface as can see in Figure 1.1 (Fey and Olson, 2010; Stoodley et al., 2002). 
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The first contact of planktonic bacteria may occur by a direct adhesion to the polymer 
surface or adhesion to host matrix proteins that cover the polymer surface, often associated with 
medical device-related infections. After this stage, structures, named microcolonies, are formed by 
the multiplication of bacteria and the production of extracellular matrix. These two stages constitute 
the initial adhesion. The biofilm maturation consists in the formation of channels of water, ion and 
nutrient exchange (three-dimensional appearance). Finally, the dispersal of single bacteria cells, or 
large cell clusters, may occur and consequently, initiate a new cycle of biofilm formation anywhere 
else in the host (Rohde et al., 2006; Schoenfelder et al., 2010). 
 
Figure 1.1 – Different stages of biofilm formation (Adapted from http://woundsinternational.wordpress.com). 
 
1.2.2 Biofilm matrix 
The biofilm matrix, sometimes also referred as the biofilm EPS, is very important for the 
survival of bacteria inside the biofilm, against adverse conditions (Flemming et al., 2000). These 
conditions can be low nutrient availability (Cerca and Jefferson, 2012), high osmotic stress 
(Hamilton and Characklis, 1989) or susceptibility of antibiotics (Howden et al., 2010).  
EPS varies in physical (such as diffusivity, thermal conductivity and rheological properties) 
and chemical properties and can account for 50 %-90 % of the total organic carbon of biofilms 
(Flemming et al., 2000; Sutherland et al., 2001). These substances are highly hydrated and may 
be hydrophilic and hydrophobic with different degrees of solubility (Sutherland et al., 2001). In 
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Gram-positive bacteria, such as S. epidermidis, the EPS produced are primarily cationic which 
produces exopolymers such as poly-y-glutamic acid (PGA) and poly-N-acetylglucosamine (PNAG) 
(PNAG will be further discussed in the biofilm development of S. epidermidis) (Percival et al., 
2000). 
The main function of the matrix is to ensure cohesion of the biofilm structure since this 
structure is not rigid and the exposure to the mechanical stresses can lead a part of biofilm will 
break and release from the surface (Rohde et al., 2006; Schoenfelder et al., 2010). There are 
more functions, not least important, such as initial adhesion (polysaccharides, proteins, DNA, 
amphiphilic molecules) (Rhode et al., 2007); intercellular adhesion (polysaccharides, proteins and 
DNA); water retention (hydrophilic polysaccharides) (Heilmann et al., 2006); protective barrier 
(polysaccharides and proteins) (Gross et al., 2001); adsorption of compounds (polysaccharides 
with charge and proteins) (Cockayne et al., 1998); enzymatic activity (proteins); nutrients source 
(any components of the matrix) (Cerca and Jefferson, 2012); exchange of genetic information 
(DNA) (Molin et al., 2003) and storage energetic (polysaccharides) (Sadovskaya et al., 2005). 
Some reports have been shown to protect bacteria against antibiotics therapy and host immune 
attack that will be further discussed (Arciola et al., 2005; Beenken et al., 2004; Cerca et al., 2006; 
Nagarajan et al., 2009; Yao et al., 2005). 
 
1.3 How S. epidermidis forms biofilms? 
 Many bacteria use signaling systems to adapt gene expression to environmental changes 
(Chen et al., 2002). Staphylococci group have two known quorum sensing (QS) systems (agr and 
luxS systems) which can be defined as bacterial intercommunication systems that control the 
expression of multiple genes, in response to cell density (Fuqua et al., 1994). These systems use 
autoinducers (AI), which are small signal molecules and when accumulated to a threshold 
concentration activates the system, directly or indirectly, controlling the transcription of specific 
genes (Yarwood and Schlievert, 2003). Gram-positive bacteria, such as S. epidermidis, use 
oligopeptide AIs that moves athwart two-component phosphorely cascades while gram-negative 
bacteria use acylated homoserine lactones (AHLs) (Carmody et al., 2004). 
The importance of agr system in biofilm formation was first shown by the group of Otto 
(Otto et al., 2001). The QS is encoded by the accessory gene regulator (agr) locus and consists of 
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four genes (agrA, agrB, agrC and agrD) that are co-transcribed. The system is organized in a two-
component of transmembrane transduction complex (agrA and agrC), a pro-signalling peptide 
(agrD) and a membrane component (agrB), responsible for the externalization of the post-
translationally modified signaling peptide which consists of an auto-inducing peptide (AIP) (Vuong et 
al., 2000; Otto et al., 2001). This system are regulated directly by DNA-binding protein agrA or 
through the regulatory RNAIII (Novick et al., 1993). The agrA activates the P2 promoter which 
controls expression of agrB, agrC, agrD, agrA and it also activates P3 promoter which drives 
expression of RNAIII and the embedded phenol-soluble modulin ∂–toxin (Queck et al., 2008). The 
QS agr system is activated during the transition from exponential to a growth stationary phase. 
Despite, the role of agr during infection is controversial (Qin et al. 2007), some studies reported 
that controls the expression of a serie of toxins (Vuong et al. 2004), virulence factors (Janzon et al., 
1989), represses biofilm formation (Vuong et al., 2000; Otto et al., 2001) and the interaction with 
innate immune system (Otto et al., 2001) that will be further discussed below.  
The QS system more recently described was luxS and this role was not well studied. 
However, it is known that luxS uses autoinducer 2 (AI-2), limits biofilm formation, virulence, 
regulate the ica gene (represses the icaADBC transcription) and production of PIA (synthesis) (Lin 
et al., 2006; Xu et al., 2006). This system is not always accompanied by endogenous AI-2 activity 
suggesting that AI-2 QS system may not be operative in some bacteria. The same study showed 
that luxS in S. epidermidis is functional and luxS-dependent gene regulation represses biofilm 
formation in vitro and pathogen success during biofilm-associated infection. Thus, by regulating 
different biofilm factors, the two QS systems of Staphylococcus, have very similar effects on the 
biofilm mode of growth (Lin et al., 2006). 
 
1.3.1 Initial Adhesion 
 Initial adhesion is characterized by the bacterial adherence to foreign body or biomaterials 
(Vacheethasanee et al., 1998). In S. epidermidis hydrophobic interactions (biofilm associated 
protein – Bap) and adhesins/autolysins (Autolysin E – AtlE)) are involved adhesion to uncoated 
surfaces (Vacheethasanee et al., 1998). The human body quickly reacts to the presence of medical 
devices by coating them with glycoproteins and proteins, such as fibronectin, vitronectin, 
fibrinogen, albumin and immunoglobulins (Begun et al., 2007). The specific binding with 
fibronectin is mediated by a surface proteins group characterized by the presence of various serine-
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aspartate repetitions. The interaction with fibronectin seems be get by techoic acids and also by a 
binding protein to the extracellular matrix of the host (Embp) (Gross et al., 2011). AtlE also mediate 
the interaction and this protein is connected to the Bap. Both proteins are responsible for 
contributing to the hydrophobic character of the cell surface, that will have an impact on the initial 
adhesion to surfaces (Mann et al., 2009). 
Staphylococci have multiple adherence factors known as microbial surface components 
recognizing adhesive matrix molecules (MASCRAMM) (Pei and Flock, 2001). The MSCRAMMs that 
have been found in most strains are SdrG, a fibrinogen-binding protein (Hartford et al., 2001), 
SdrF, a colagen-binding protein (Arrecubieta et al., 2007), and SdrH an elastin-binding protein 
(Arrecubieta et al., 2009). However, the most studied is SdrG, that has been described as 
important to promote S. epidermidis adhesion to fibrinogen-coated surfaces (Hartford et al., 2001). 
Recent studies demonstrated that SrdG is responsible, also, for promoting platelet adhesion and 
aggregation (Brennan et al., 2009). SdrF has also been demonstrated during ventricular assist 
device driveline-related infection (Arrecubieta et al., 2007) (Figure 1.2). 
 
Figure 1.2 - The S. epidermidis cell surface (Adapted from Otto, 2009). 
 
1.3.2 Biofilm Maturation 
 The biofilm maturation is achieved by adhesion proteins, eDNA, techoic acids and 
polysaccharides, allows the development of the typical three-dimensional structure of the biofilm 
(Rupp et al., 1999). S. epidermidis growing within a biofilm consists, at least, four metabolic states: 
aerobic growth, anaerobic growth, dormant cells and dead cells (Rani et al., 2007). 
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One specific operon that is consistentely upregulated within biofilm populations of S. epidermidis, 
in contrast to cells growing in planktonic form, is the arginine deiminase operon (ADI) (Beenken et 
al., 2004). This pathway is used to catabolize arginine under microaerobic or anaerobic conditions 
to generate ammonia and ATP (Abdelal, 1979) and under anoxic conditions arginine serve as 
carbon source (Makhlin et al., 2007). One study report that the generation of ATP through arginine 
catabolism is an important aspect for biofilm maturation (Diep et al., 2008). The pseudopeptide 
polymer PGA is very important and synthetized by the gene products of the cap locus which seems 
to be increased during the biofilm mode growth important (Chokr et al., 2007). PGA promotes 
growth function of S. epidermidis at high salt concentrations, in pathogenesis is only known this 
specie (Fluckiger et al., 2005) and contributes to osmotolerance which indicates a role for S. 
epidermidis colonization (Gerke et al., 1998). 
The best studied mechanism of biofilm accumulation is related to the production of β1,6-
poli-N-acetylglucosamine (PNAG) also referred as polysaccharide intercellular adhesion (PIA), which 
is produced by many S. epidermidis strains (Mack et al., 1996; Wang et al., 2004). The 
biosynthesis of PNAG is the result of the expression of the genes that constitutes intercellular 
adhesion (ica) locus, which compromises icaADBC operation and icaR gene (Knobloch et al., 
2004) which encodes a regulatory protein (Wang et al., 2007). The icaADBC codifies icaA and icaD 
proteins (N-acetilglucosamine transferases) responsible by development chain activated of the N-
acetilglucosamine monomers (GlcNAc) (Gerke et al., 1998). De-acetylation from activated N-
acetylglucosamine (GlcNAc) monomers by the ica gene produces positive charges into the 
otherwise-neutral polymer which is necessary for surface binding of PNAG. GlcNAc is synthetized 
by the membrane-located activity (step 1, Figure 1.3a) (Conlon et al., 2004). The PNAG chain is 
exported by the icaC membrane protein (step 2, Figure 1.3a). Then, icaB de-acetylase, in cell 
surface, removes some of the N-acetyl groups giving a cationic character which is necessary for 
surface attachment (step 3, Figure 1.3a) (Conlon et al., 2004). icaC responsible for the elongation 
of monomers and subsequent transport to the bacterial surface (Gerke et al., 1998) and the icaB 
responsible for the partial de-acetylation process (Kristian et al., 2008). This process introduces a 
positive charge on the polysaccharide, which contributes to the connection of this surface and 
other biological functions involved in biofilm formation and evasion of the host immune system that 
will further discussed. The expression of  icaADBC operon is regulated by the icaA promoter or 
through expression of icaR and both are controlled by a series of regulatory proteins such as SigB, 
SarA, SarZ, ClpP, tricarboxylic acid (TCA) cycle and luxS (Figure 1.3b) (Handke et al., 2007; Wang 
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et al., 2007). Both SarA and SarZ are required for icaADBC transcription and subsequent PIA 
synthesis (Tormo et al., 2005; Wang et al., 2008). Cerca et al. (2008), demonstrated that in S. 
aureus, SarA and ∂B are required for icaR expression and icaR does not significantly affect its own 
transcription. 
 Importantly, some studies demonstrated that PNAG is not essential for biofilm formation, 
since S. epidermidis strains lacking the ica gene can form biofilms and the surface proteins, Aap 
and Bap, may be additionally or exclusively responsible for biofilm formation (Rhode et al., 2005). 
Colonies that produce PNAG grow as crusty, irregular colonies whereas, PNAG-negative colonies 
are smooth and creamy (Freeman et al., 1989). Some ica-negative S. epidermidis strains seems to 
be mediated by Bap and accumulation associated protein (Aap), which requires proteolytic 
activation and zinc ions (Zn2+) (Conrady et al., 2008). Zn2+ is crucial for the modular association of 
G5 tandem repeats that may underlie the formation of Aap based fibril-like structures on the 
bacterial surface (Figure 1.2) and, consequently, mediates the adherence to corneocytes 
implicating a further role in adherence to skin (Macintosh et al., 2009). Based in some studies, 
Aap is found approximately 90 % (Sun et al., 2005) and Bap between 15 % - 45 % (Rohde et al., 
2007; Bowden et al., 2005) supporting the importance of their presence in biofilm formation.  
 
Figure 1.3 - The exopolysaccharide poly-N.acetylglucosamine (Adapted from Otto, 2009). 
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In the detachment process, biofilm release cells in order to maintain the survival of 
community, promoting the spread of bacteria and leading to the formation of new sites of infection 
(Voung et al., 2003). Biofilms can be dispersed by many processes such as shedding of daughter 
cells from actively growing cells (Vuong et al., 2004), as a result of low nutrient level (survival 
mechanism) (Gross et al., 2001), quorum sensing (recognition of nearby cell density) or shearing 
of biofilm aggregates because of flow effects (Vuong et al., 2003). The mechanisms underlying the 
release of the cells are poorly understood but many factors can be involved such as mechanical, 
enzymatic degradation of exopolymers and the rupture of non-covalent interactions by surfactant 
molecules (phenol soluble modulins - PSM) or ∂-toxins (Otto, 2009). 
 Little is known regarding dispersal and detachment mechanisms, however, in both S. 
aureus and S. epidermidis this process is agr dependent (Boles and Horswill, 2008). A model has 
been proposed for S. aureus, which involves agr expression which exposes layers of biofilm 
promoting the detachment of cells clusters, controlling biofilm expansion (Otto et al., 2001). 
Likewise, in S. epidermidis agr activity is limited to the biofilm surface which indicates the existence 
of a common staphylococcal mechanism of QS-controlled biofilm detachment (Little and Lvins, 
1999). 
 Based in one study, S. epidermidis agr mutants showed increased biofilm development 
and colonization in a rabbit model (Vuong et al., 2004). It is hypothesized that the increased 
biofilm thickness in agr mutants is due to the loss of ∂-toxin and other phenol-soluble modulins 
(Otto, 2009). These molecules act as surfactants that inhibit noncovalent interactions of bacteria at 
the surface of biofilm (Vuong et al., 2004). Detachment was related to increased protease activity 
in biofilm effluent and was related to increased expression of Aur metalloprotease and the 
SplABCDEF serine proteases. It is unclear what function these proteases may have in detachment 
of PNAG/ Aap-Bhp dependent biofilm in S. epidermidis (Boles and Horswill, 2008). Therefore, 
detachment is not just important for promoting genetic diversity, but also for escaping unfavorable 
habitats aiding in the development of new niches which, consequently, have a very important 
implication in patients with medical devices (Raad et al., 1992). 
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1.4 The impact of biofilms in health 
S. epidermidis can account for more than 90 % of the resident flora in humans. Despite its 
generally innocuous nature, in last 20 years emerged a frequent cause of nosocomial infections 
(Cogen et al., 2008). Up to 60 % of all nosocomial infections are caused by biofilms on medical 
devices (Donlan and Costerton, 2002). In United States of America, nosocomial infections are 
responsible for 1.7 million of infections and 99 thousand deaths per year (CDC, 2004). In Portugal, 
it his estimated than 10 % of all infections are hospital acquired (Pina et al., 2013). It is estimated 
that biofilms are involved in 65 % of all human infections (Lewis, 2007). 
 
1.4.1 Biofilm infections in indwelling medical devices  
The microbial infections associated to the biofilm formation are recognized as etiologic 
agents of many chronic and persistent infections (Costerton et al., 1999). Probably, due to the very 
slow growth in the biofilms, these infections are difficult to diagnose and treat with conventional 
approaches (Howden et al., 2010). With the increase of medical devices, the incidence of these 
infections also increased the incidence and prophylaxis and limiting the colonization of medical 
devices the simplest and effective measures to be taken (Rohde et al., 2007). 
Medical devices (Figure 1.4) are made out of abiotic materials such as metals, polymers 
(silicone), but may also contain biological materials such as devitalized bone, blood vessels, 
muscle fascia from autologous (venous bypass), allogeneic (processed bone), or xenogeneic 
sources (porcine heart valve) (Darouiche, 2004; Zimmerli and Trampuz, 2011). Interestingly, 
neither synthetic nor devitalized biological devices are rejected by the body, despite the fact that 
host reacts to such implants in different ways depending upon the biocompatibility of the device. 
However, no implant is completely inert after implantation (Anderson et al., 2008; Zimmerli et al., 
2004). There are two different type of devices that interact very differently with the host. Whereas, 
intravascular implants mainly interact with coagulation factors and circulating blood cells, 
extravascular implants interacting with surrounding tissue, interstitial fluid and attracted phagocytes 
(De Man et al., 2011). Permanent implants cannot be removed without compromising the replaced 
function. Therefore, the primary goal is to prevent implant failure due to mechanical reasons or 
infection (Zimmerli, 2006).   
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Biofilm infections occur in the hospital environment, especially in very young or old 
immunocompromised patients (Howden et al., 2010). These infections are usually associated with 
persistent and relapsing infections such as otitis media (Hall-Stoodley et al., 2006), native valve 
endocarditis (Martin-Davila et al., 2005), cystic fibrosis (Bjarnsholt et al., 2009), periodontitis and 
caries (Zjinge et al., 2010), chronic bacterial prostatitis (Mazzoli, 2010), tissue necrosis (Hall-
Stoodley, 2008), catheter-related septicaemia and emboli with serious complications to the host 
(clumps of cells which also contain platelets or erythrocytes) (Costerton et al., 1999). 
Unfortunately, biomaterial associated infection compromises the quality of life, has a high morbidity 
and is even associated with mortality. In addition has a high economic impact, since treatment 
costs more than the primary implantation of the device (Batoni et al., 2010; Ketonis et al., 2010).  
 
 
 
 
 
 
 
 
Figure 1.4 - Schematic model of phases involved in S. epidermidis biofilm formation on medical devices (Adapted from 
Heilmann and Götz, 2013). 
 
1.4.2 Immune response and resistance for antibiotics  
 The most important clinical consequences related to biofilm infections is their higher 
resistance to antibiotic and to the host immune system (Otto, 2009). The host immune response is 
a structured system and involves several biological processes that protect the organism against 
diseases (O´Gara, 2007). It is divided into innate (primary barrier such as skin) and acquired 
immunity (lymphocytes) as can see in Figure 1.5 (Riken, 2013). S. epidermidis has to cope with 
various mechanisms of host defense during the infection, such as antimicrobial peptides (AMPs), 
that are present in human skin, or phagocytes, among which neutrophils or polimorphonuclear 
leucocytes (PMNs) have a proeminent role (Knoblock et al., 2004; Sadyvok and Bayles, 2012). 
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As mentioned above, PNAG, is involved in evasion of S. epidermidis biofilms to the immune 
system of the host (Wang et al., 2004). PNAG has positive a charge, which is rare in bacterium 
polysaccharides (Opperman-Sanio and Steinbuchel, 2002). This charge prevents the action of 
AMPs, also with positive charge, by electrostatic repulsions (Vuong et al., 2004). However, pattern 
recognition receptors present in bacterium surface by phagocytic cells difficult the binding between 
antibodies and proteic factors of the complement system (Cheung et al., 2010). Preventing the 
binding of these last two components of bacteria cell surface limits the process of opsonization 
and, consequently, phagocytosis of these bacteria by phagocytic cells (O´Gara, 2007). 
Besides the protection that PNAG confers to the bacteria, it can also stimulates the 
production of pro-inflammatory cytokines such as interleukins (IL) 8 and IL-6 by activating toll-like 
receptor 2 (TLR2) (Cheung et al., 2010). The stimulation of the immune response by biofilms may 
seem a non-sense in respect of being hostile to pathogens. On the other hand, a continuing 
inflammatory response causes damage to the surrounding tissue promoting susceptibility to 
bacterial adhesion and thus biofilm development locations (Sadyvok and Bayles, 2012). 
 On the other hand, biofilms can be up 1.000 times more tolerant to antibiotics than 
equivalent planktonic cultures (Hoyle and Costerton, 1992; Mah and O´Tole, 2001). Resistant 
bacteria can occur during or after an antibiotic treatment (Beiji et al., 2004; Hurford et al., 2012). 
Whilst biofilm cells may employ a variety of mechanisms to resist the action of antimicrobial agents 
(Mah et al., 2003), studies have shown that a number of key factors contribute to reduced 
antimicrobial susceptibility of biofilms (Percival and Bowler, 2004). Several other agents with 
bactericidal and/or bacteriostatic effects, many of them available in a wide range of household 
products such as disinfectants, are responsible for resistant bacteria (Levy, 2000; McMurry et al., 
1998). 
 In S. epidermidis, specific antibiotic resistance genes are widespread.  In many countries, 
including United States, 75 % - 90 % of all hospital isolates of S. epidermidis are resistant to 
methicillin (Diekema et al., 2001). This resistance is encoded on mobile genetic elements (MGEs), 
known as the staphylococcal cassette chromosome mec (SCCmec) (Diep et al., 2008; Wisplinghoff 
et al., 2003). This cassette chromosome contains the mecA gene which encodes a penicillin-
binding protein, PBP2a (Chambers et al., 1985). S. epidermidis has also acquired resistance also 
rifamycin, fluoroquinolones, gentamycin, tetracycline, chloramphenicol, erythromycin, clindamycin 
and sulphonamides (Rogers et al., 2009). Despite widespread resistance to methicillin and other 
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antibiotics, 80% of catheters infected with S. epidermidis can be still treated with antibiotics such 
as vancomycin and chitosan (Raad et al., 2007; Neoh and Kang, 2009). The frequency of antibiotic 
resistance reflects the overuse of antibiotics. Furthermore, the ubiquity of S. epidermidis as a 
human commensal microorganism renders this bacterium an optimal carrier and reservoir for 
antibiotic resistance genes (Miragaia et al., 2005). 
 
Figure 1. 5 - Innate and Adaptative immunity (Adapted from http://www.rikenresearch.riken.jp). 
 
1.5 Biofilm gene expression 
The biofilms can quickly adapt to new conditions, phenotypically, genetically and 
structurally, and changing internal and external conditions, consequently, can result in the 
resistance to many antibiotics or mechanisms of the host defense. These features provide an 
important advantages compared with their planktonic existence (Hoyle and Costerton, 1992). S. 
epidermidis has a substantial, genome-wide adaptation to the biofilm mode of growth, including 
downregulation of basic cell processes as nucleic acid, protein and cell wall biosynthesis (Sadyvok 
and Bayles, 2012). Therefore, it is very important to study the expression of genes and their 
influence or contribution in biofilm formation, to better understand the S. epidermidis virulence. 
Since biofilm formation is one of the major virulence factors for these strains (Table 1.1). 
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Table 1.1 - Main recognized virulence factors of S. epidermidis (Adapted from Otto Nat. Rev. Microbiol., 2009, 7(8): 
555-67). 
Virulence factors Gene Function 
Biofilm factors 
Primary attachment to abiotic surfaces 
Aae Aae Autolysin/adhesion 
AtlE atlE Autolysin/adhesin; affects surface hidrophobicity 
Teichoic acids Multiple byosinthetic genes Affect attachment (only demonstrated in S. aureus) 
Primary attachment to matrix proteins (MSCRAMMs) 
AtlE and Aae atlE and Aae Bind to many matrix proteins 
Embp Embp Binds to fibronectin  
GehD gehD Binds to collagen 
SrdF SrdF Binds to collagen 
SrdG (Fbe) SrdG (Fbe) Binds to fibrinogen 
SrdH SrdH Putative binding function 
Intercellular aggregation 
Aap aap Protein intercellular adhesion 
Bhp bhp Protein intercellular adhesion 
PNAG (PIA) icaA, icaD, icaB and icaC Polysaccharide intercellular adhesion 
Teichoic acids Multiple byosinthetic genes Components of the biofilm matrix 
Exoenzymes 
Cysteine proteases SspB and 
Ecp sspB Maybe responsible for tissue damage 
Glutamylendopeptidase, GluSE 
and serine proteases Esp and 
SspA 
sspA Degrades fibrinogen and complement factor C5 
Lipases GehC and GehD 
gehC and gehD 
Maybe responsible for the persistence in fatty acid 
secretions 
Metalloprotease/ elastase SepA sepA Involved in lipase maturation, AMP resistance and protein tissue damage 
Protective exopolymers 
PGA capA, capB, capC and capD Protects from AMPs and phagocytosis 
PIA icaA, icaD, icaB and icaC 
Protects from IgG, AMPs, phagocytosis and 
complement 
Resistance to AMPs 
Aps system apsR, apsS and apsX 
Senses AMPs and regulates AMP resistance 
mechanism 
SepA protease sepA Involved in AMP degradation 
Toxins 
 
PSMs psmα, psm∂, psmε, hld Pro-inflammatory cytolysins 
Other factors 
SitA, SitB and SitC sitA, sitB and sitC Involved in iron uptake 
 AMP, antimicrobial peptide; Aap, accumulation-associated protein; Bhp, Bap homologue protein; IgG, 
immunoglobuline G; MSCRAMM, microbial surface component recognizing adhesive matrix molecules; PGA, poli-ɣ-
glutamic acid; PIA, polysaccharide intercellular adhesin; PSM, phenol soluble modulin.  
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1.5.1 Techniques used for gene expression determination 
In common gene expression studies, there are three fundamental experimental steps 
before obtaining the final results: RNA extraction, reverse-transcriptase reaction and quantitative 
polymerase chain reaction (qPCR). 
 RNA extraction method consists in purify RNA from biological samples. The quality, purity 
and integrity are an important requirement for any RNA-based analysis (Bustin et al., 2005). The 
samples have intrinsic properties that can affect yield RNA with different quality (Nolan et al., 
2006).  Furthermore, the cell wall of gram-positive bacteria´s are constituted by a thicker layer of 
peptidoglycan compared with gram-negative bacteria´s and, consequently, it´s more difficult to 
obtain a good quantity and quality of RNA (França et al., 2012) because the lysis of bacterial cell 
and the high content of proteins and polysaccharides, major component of the biofilm matrix, 
which is estimated to compromise about 90% of the total biofilm biomass (Flemming, 2010). Due 
to his, the bacterial cell lysis and nucleic acid purification seems to be difficult in RNA extraction 
methods, as well as, the purified RNA which still contains inhibitory substances (Juntilla et al., 
2009; Santiago-Vásquez, 2006). 
 Some studies showed that different RNA extraction methods can yield RNA with distinct 
quality and this can be explained by the complexity of biological samples (França et al., 2011; 
Schowchow et al., 2012; Shulman et al., 2012). So the type of extraction method to choose is 
crucial: enzymatic, chemical and/or mechanical. For this case in specific, S. epidermidis, the best 
kits are based on organic extraction and a mechanical lysis step results in a higher yields. However 
the RNA yield and RNA purity were not a relationship directly in stability of gene expression (França 
et al., 2011; Sieber et al., 2010). Carvalhais et al. (2013), have recently shown that the indicators 
of quality did not correlate, ever, with an authentic gene expression quantification which has high 
relevance since the indicators that guarantee RNA quality may not to be enough to determine the 
authenticity of bacterial gene expression. Nonetheless, the purity and integrity can impact the 
accuracy of processing or analytical techniques such as complementary DNA (cDNA) synthesis and 
quantitative real-time PCR (Bustin et al., 2005; Nolan et al., 2006).  
 The quantification of mRNA has proved to be a useful tool to validate the transcriptional 
measurements associated with switching to the pathogenic mode of infection (Yao et al., 2005; 
Beenken et al., 2004; Li et al., 2008; Zhu et al., 2010). Due to the low half-cycle of RNA 
molecules, a strategy commonly used to quantify the amount of messenger RNA (mRNA) is to 
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convert those molecules in complementary cDNA. This is achieved by the reverse transcriptase 
polymerase chain reaction (RT-PCR) (França et al., 2012).  Some reports indicated that reverse 
transcription reaction is very important since during the optimization of cDNA synthesis with 
commercial kits and revealed high variability in the results by some of the kits tested (França et al., 
2012; Sieber et al., 2010). Besides of that, is necessary more studies to a better understand the 
implication of this step.  
The qPCR technique has been widely used in gene expression experiments due to its high 
sensitivity allowing the accurate quantification of very small amount of starting material. This 
method is used to amplify and quantify a targeted DNA molecule by fluorescence detection 
(Didenko et al., 2006). The quantification can be absolute or relative: absolute quantification when 
the objective is to determine the exact number of copies of mRNA molecules present in the sample 
and relative quantification expresses the results, not as an absolute amount, but as n fold change 
on expression values (Raajevan et al., 2001; Fang and Cui, 2011).  
Sieber et al. (2010), also reported there is some variability associated with the qPCR kit 
used. However, what is not known is how the different experimental steps, influence the observed 
gene expression variability. 
 
1.6 Study objective 
 The main goal of this work was to demonstrate and understand the influence in the 
variability of gene expression quantification, by the individual experimental steps required for gene 
expression quantification, namely bacterial growth, RNA extraction, reverse transcriptase and real-
time quantitative PCR. Additionally, we proposed an optimized protocol to enhance gene expression 
reproducibility in S. epidermidis biofilms. 
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2.1 Introduction 
Transcriptional measurements are often used to study S. epidermidis virulence (Batzilla et 
al., 2006; Dai et al., 2012; Fluckiger et al., 2005; Handke et al., 2004).  
The RNA must have high quality for downstream applications like qPCR (Nolan et al., 
2006). Normal quality parameters include purity, integrity and yield of RNA (Fleige and Pfaffl, 
2006) and, according MIQE guidelines, RNA should be pure, presents high integrity and sufficient 
quantity (Bustin et al., 2009). All these parameters can influence gene expression. As mentioned 
before (in Chapter I), different RNA extraction methods (Atshan et al., 2011; França et al., 2011; 
Pinto et al., 2009) as well as the complexity of biofilm matrix can yield distinct RNA quality 
(Radstrom et al., 2004; Tichopad et al., 2004). França et al. (2012) demonstrated that RNA quality 
indicators did not, ever, correlate with a reliable gene expression quantification. Furthermore, RNA 
isolation procedure such as ethanol or phenol may inhibit the PCR process (Bar et al., 2012; 
Wilson, 1997). Sieber et al. (2010) reported that when low concentration of RNA is used, the 
variability in gene expression is higher. Furthermore, gene expression can also be influenced by 
other factors, such as contaminants or loss of RNA integrity (Carvalhais et al. (2013)). However, 
what is not known, so far, is the intrinsic contribution, by each individual experimental procedure, 
to the observed variation in gene expression studies. 
The main objective of the work described in this chapter was to understand the origin of 
variability in gene expression studies, in S. epidermidis biofilms. To achieve that, we designed an 
experimental protocol that would allow us to determine the individual contributions of each of the 
proposed experimental steps, to the final observed variability, namely the biological variability, from 
one biofilm to another, the variability from different RNA extraction procedures, the variability from 
different reverse transcriptase reactions and finally, the variability of the qPCR quantification (Figure 
2.1). The genes selected for this study have different functions in  the physiology of S. epidermidis: 
aap gene is involved in biofilm accumulation and icaA gene is involved in biofilm maturation 
(Vandecasteele et al, 2003); pgi gene is involved in glycolysis (Gill et al., 2005); lrgB gene is 
thought to be involved in induced cell death, lysis and stress environment response (Sadyvok and 
Bayles, 2012) and fmtC gene is involved in the resistance to antimicrobial peptides (Bao et al, 
2012) and mechanism of the host´s immune system. 
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1) Biologic variability: 
 
                                                  
2) RNA extraction variability: 
 
 
3) cDNA synthesis variability: 
 
 
4) qPCR variability: 
 
 
Figure 2.1 - Scheme representation of the experimental design aiming to determine the source of gene expression 
variability. 
 
2.2 Materials and Methods 
 
2.2.1 Bacterial strain and growth conditions 
 One well-known biofilm-forming strain was used in this study: S. epidermidis RP62A 
(PubMed accession number: PRJNA57663, ID: 57663) was replicated in petri plates (Frilabo) with 
Tryptic Soy Agar (TSA, Liofilchem) and were incubated for 48 H at 37º C. For the biofilm assays, 
two growth media were prepared: Tryptic Soy Broth (TSB, 30 g/L – Oxoid) and TSBG (TSB 
supplemented with 1% (w/v) of glucose). 
 
2.2.2 Biofilm formation assays 
 A pre-inoculum was prepared, in plastic tubes of 10 mL (Frilabo), containing 2 mL of TSB. 
A fresh TSA plate with S. epidermidis was used as inoculum. The strain was grown overnight at 
Biofilm growth 
 
RNA extraction cDNA  synthesis qPCR 
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37ºC with 120 rpm in a shaker-incubator (N-Biotek, NB-205Q). Then, the culture was dilute in 
TSBG to adjust the O.D. between 0.25-0.30 by spectrophometer reading (Spectronic® 20 Genesis, 
Spectronic Instruments) with 640 nm filter. After adjusted, 15 µL of the diluted suspension was 
placed in a 24-well plate (Thermo Scientific) with 1 mL of TSBG and incubated with same 
conditions for 24 H. The spent media was removed of the 24-well plates and biofilms were washed 
and resuspended in 1 mL of 0.9 % (w/v) Sodium Chloride (NaCl), to remove planktonic bacteria. 
The resuspended biofilm (dislodged by scraping) was then transfer to a 1.5 mL RNAse and DNAse 
free eppendorf tube (Bioplastics, Frilabo). 
 
2.2.3 Customized RNA extraction protocol 
The protocol described here combines mechanical and chemical lysis along with silica-
membrane RNA isolation (E.Z.N.A.TM Total RNA, VWR, Omega Bio-Tek). Briefly, it consists in 
suspend bacterial pellet in 500 µL of TRK lysis buffer provided by the kit (supplemented with β-
mercaptoethanol, Sigma) plus 500 µL of phenol (AppliChem, Frilabo) after centrifuged at 
maximum speed for 10 minutes in Centrifuge 5415R (eppendorf) and transferred into a 2 mL safe 
lock tubes with 0.5 g of glass beads (150-212 µm, MP Biomedicals, IIIKrich, France).  This mixture 
was vortexed (Vortex V-1 Plus, Biosan, Frilabo) for 20 seconds before using the FastPrep® Cell 
disruptor (BIO 101, ThermoElectron Corporation, Thermo Scientific) with setting 6.5 and 35 
seconds. The samples were then cooled on ice for 5 minutes and the beat-beading step repeated 
twice. Afterwards, samples were centrifuged (Centrifuge ScanSpeed mini blue, Labogene) at 
12,000 g for 2 minutes and supernatants transferred 700 µL into a 2 mL DNAse/RNAse free tube 
(Bioplastics) and added equal volume of 70 % ethanol (Fisher Scientific). The samples, 700 µL, 
were transferred to the RNA isolation column (including any precipitate) and centrifuged (Centrifuge 
ScanSpeed mini blue, Labogene) at 12,000 g for 30 seconds at room temperature (RT). The flow-
through was discarded and each column was reinserted into a new collection tube. To wash the 
columns, 500 µL of wash buffer I (provided by the kit) was added to each column and centrifuged 
(Centrifuge ScanSpeed mini blue, Labogene) at 10,000 g for 30 seconds at RT. The flow-through 
was discarded and the same collection tube was used. After that, 500 µL of was buffer II (provided 
by the kit) was added to each column and centrifuged (Centrifuge ScanSpeed mini blue, Labogene) 
at 10,000 g for 30 seconds at RT. The flow-through was discarded. This step was repeated one 
more time but either the flow-through as collection tube were discarded. Then, was reinserted into 
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a new collection tube and centrifuged (Centrifuge ScanSpeed mini blue, Labogene) at 16,000 g for 
3 minutes to remove any trace of the wash buffer II that contains ethanol that is known to influence 
downstream applications and the columns are transferred to a 1.5 mL DNAse/RNAse free tube 
(Bioplastics, Frilabo). Finally, RNA elution was achieved by adding 50 µL of DEPC-treated water 
(provided by the kit) to the center of the membrane and centrifuged at 10,000 g for 1 minute. 
 
2.2.4 DNAse Treatment 
5 µL of DNase I reaction buffer (Fermentas, Frilabo) and 2 µL of DNase I (Fermentas, 
Frilabo) were added to 45 µL of the RNA samples, mixed thoroughly by pipetting up and down, and 
incubated at 37ºC for 30 minutes in a thermal block (Alfagene). Then 5 µL of 25 mM EDTA 
(Fermentas, Frilabo) was added to the mixtures, mixed by pipetting up and down, and incubated at 
65ºC for 10 minutes, in a thermal block (Alfagene), to inactivate the DNase I enzyme (Fermentas, 
Frilabo).  
 
2.2.5 RNA Quality Determination 
 The concentration and purity of the RNA sample was determined with a NanoDrop 1000TM 
(Thermo Scientific). The purity was achieved based in two absorbance ratios: the absorbance ratio 
A260/A280 is an indicator of protein contamination and the absorbance ratio A260/A230 is an indicator of 
polysaccharide, phenol and/or chaotropic salt contamination (Tavares et al, 2011). High quality 
RNA has both ratios higher than 1.8 (Glasel, 1995). Two independent measurements of each same 
sample were performed and average. The integrity of the total RNA was assessed by visualization 
of the 23S/16S banding pattern. RNA samples were analyzed in 1.0 % agarose gel stained with 
Midori Green DNA (Nippon Genetics Europe GmbH, Germany) at 90V. RNA was stored at -80ºC 
until further use.  
 
2.2.6 cDNA synthesis  
 The commercial kit used was RevertAaidTM First Strand cDNA Synthesis Kit (Fermentas, 
Frilabo) and the total RNA was normalized to a 100 µg/µL. The reverse transcriptase reaction was 
performed accordingly to manufacturer instructions, with small modifications with a final volume of 
10 µL, as optimized before (França et al., 2012). Briefly, in one 0.2 mL DNAse/RNAse free tube 
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(Bioplastics, Frilabo) was added the respective quantity of water, 1 µL random primers (NZYtech, 
VWR) and RNA in order to obtain a final volume of 10 µL. Then, were heated at 65ºC for 5 
minutes, in a heat block (Alfagene) and then placed on ice for 5 minutes. This heat-cool process is 
advisable for RNA templates GC-rich or that contains secondary structures. In a 0.2 mL 
DNAse/RNAse free tube (Bioplastics, Frilabo), 5 µL of the prepared RNA was added to the 2 µL of 
buffer (Thermo Scientific, Frilabo), 1 µL of dNTPs (Thermo Scientific, Frilabo), 0.75 µL of reverse 
transcriptase (Thermo Scientific, Frilabo), 0.25 µL of Ribolock (RNAse inhibitor, Thermo Scientific, 
Frilabo) and 1 µL of water nuclease free (Thermo Scientific, Frilabo) for each gene. In another 
tubes 5 µL was added of the previously prepared RNA samples to 5 µL of water (Reverse 
Transcriptase minus Negative control - NRT). NRT is used to determine the possibility of genomic 
DNA carry-over with absence of reverse transcriptase enzyme. PCR amplifications were performed 
using thermal cycler (MJ MiniTM Personal Thermal Cycler, Bio-rad). The following cycle for thermal 
cycle were 25ºC during 5 minutes, 42ºC during 60 minutes, 70ºC during 10 minutes and 4ºC 
forever. Primers efficiencies were determined by the dilution method.  
 
2.2.7 Gene expression quantification  
Biofilm gene expression was determined by qPCR. qPCR analysis was performed using mix 
iQTM SYBR Green Supermix (Bio-Rad) in a 10 µL reaction volume. Each reaction contained 2 µL of 
the diluted cDNA or no-RT control (400 fold dilution of the resulting cDNA template in DEPC-treated 
water), 5 µL of master mix, 1 µL of primer mixture (10 µM of each forward and reverse primers) 
and 2 µL of nuclease-free water as described before (França et al., 2012). Information about de 
primers used are listed in Table 2.1.  
qPCR run was performed on a CFX 96 (Bio-Rad) with the following cycle: 95ºC for 30 
seconds, 39 cycles of 95ºC for 5 seconds, 60ºC for 15 seconds,  68ºC for 15 seconds and the 
products were analyzed by melting curves for unspecific products or primer dimer formation. qPCR 
products were analyzed by melting curves to confirm that if the desired product was only amplified 
and all reactions were run in triplicate with two controls namely no-template control (NTC), which is 
composed by 5 µL of mix and 5 µL of nuclease-free water, for each set primer and NRT as 
mentioned above were included in each run. The expression of aap, icaA, pgi, lrgB and fmtC were 
normalized to the expression of the housekeeping gene 16S rRNA and was performed by the Livak 
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method and the gene expression quantification was calculated by: CT= CT (housekeeping gene) 
– CT (target gene) (Livak and Schmittgen, 2001). 
Table 2.1 - Primers, amplicons, functions and melting temperature for the primers used in this study. 
Target gene Primer sequence (5´to 3´) Amplicon 
size (bp) 
Melting Temperature 
(ºC) 
16S FW: GGGCTACACACGTGCTACAA 176 59,79 
59,85 RV: GTACAAGACCCGGGAACGTA  
aap FW: GCACCAGCTGTTGTTGTACC 190 59,22 
59,98 RV: GCATGCCTGCTGATAGTTCA 
lrgB FW: ATATCGCAAGCGCGAAGTAT 165 59,87 
59,61 RV: ATTGCTGTCGTTGCAGCTT 
fmtC FW: CGCCCTCATCATAGCATTG 182 60,19 
60,03 RV: CCAATTGGATCACCCAAAAC 
icaA FW: TGCACTCAATGAGGGAATCA 134 60,20 
59,99 RV: TAACTGCGCCTAATTTTGGATT 
pgi FW: TACTACGACAGAACCAGCAG 170 54,05 
53,95 RV: CATCAGGTACAACAAACGTC 
Bp, base pairs; FW, forward; RV, reverse. 
 
2.3 Results and Discussion  
 Gene expression in S: epidermidis biofilm samples has been shown to have a high 
variability, that can be related to the experimental protocol, as discussed in the introduction of this 
chapter. Here, we aimed to determine that intrinsic variability of each of the experimental steps 
required to quantify the expression of five independent genes.  
 First of all, we determined the integrity of RNA samples and eliminate all that shown 
significant loss of integrity (such as sample B, in figure 2.2). Then, we determined the efficiency of 
each primer set. The efficiency was determined at different temperatures, ranging from 50ºC to 
65ºC. The best possible combination of efficiencies was obtained at 60ºC (Table 2.2). 
Furthermore, in all our experiments, all RNA samples extracted were absent of significant genomic 
DNA, as determined by an average cycle threshold difference of 18 ± 3 which indicates a 
maximum error of 0.0003 %.  
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Figure 2.2 – Example of integrity of RNA samples of RP62A: (A) DNA marker, (B to E) independent RNA samples. 
 
Table 2.2 - Efficiency of five genes studied. 
Genes 16S aap lrgB fmtC icaA pgi 
Efficiency (%) 92,5 95,2 90 97,8 90 85 
 
Since external factors can interfere in gene expression measurements, all experimental 
conditions were strictly maintained, namely the composition of growth medium, agitation, 
temperature and time of incubation, as well as the material of the 24-well plates. We started by 
determining the biologic variability observed in four independent 24 H biofilms. Each biofilm was 
formed in a different day and the RNA was extracted and stored at -80ºC until further use. The 
reverse transcriptase and qPCR reactions were done simultaneously. Table 2.3 represents the 
gene expression determination for each individual qPCR run. 
As it can be observed, in table 2.3, gene expression variability was dependent of the tested 
gene. Therefore, we calculated the coefficient of variability obtained for each gene. As can be seen 
in Figure 2.3, gene variability ranged from 27 % (lrgB) to 88 % (icaA). The overall gene expression 
variability, as determined by the average of the five tested genes variability, was 61 ± 26 %. 
Interestingly, the genes that presented higher variability were icaA and pgi, both related to 
the carbon metabolism and subsequent biofilm formation (Cerca, 2012). The use of glucose is 
often considered fundamental for biofilm formation (Holá et al., 2006); however, excess glucose 
will induce the medium acidification (Cerca et al., 2011) and this may interfere with the stability of 
mRNA. 
 
(A) (B) (C) (D) (E) 
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Table 2.3 – Quantification of gene expression normalized to 16S, using four independent biofilms. 
Sample aap lrgB fmtC icaA pgi 
 
Biofilm 1 
2,32E-04 5,91E-05 7,32E-05 2,04E-04 8,46E-04 
2,96E-04 5,54E-05 6,84E-05 2,15E-04 1,08E-03 
3,18E-04 6,59E-05 7,08E-05 1,82E-04 8,76E-04 
 
Biofilm 2 
5,49E-05 4,88E-05 1,85E-05 2,28E-05 1,39E-04 
6,05E-05 4,74E-05 1,86E-05 2,51E-05 1,15E-04 
6,87E-05 4,73E-05 2,08E-05 2,22E-05 1,45E-04 
 
Biofilm 3 
1,35E-04 5,91E-05 3,12E-05 4,70E-05 2,43E-04 
1,18E-04 5,68E-05 3,15E-05 4,73E-05 1,16E-04 
1,33E-04 5,17E-05 3,36E-05 2,77E-05 3,19E-04 
 
Biofilm 4 
1,97E-04 8,99E-05 4,25E-05 5,25E-05 2,94E-04 
1,79E-04 9,55E-05 5,10E-05 6,97E-05 2,63E-04 
2,78E-04 8,65E-05 7,41E-05 8,07E-05 2,60E-04 
 
 
 
Figure 2.3 - Coefficient of biological variability (in %) of gene expression of aap, lrgB, fmtC, icaA, pgi. 
 
After assessing the variability associated with independent biological replicates, we 
proceeded with the next stage of our experimental design. In order to determine the intrinsic 
variability obtained from the RNA extraction procedure, we performed four different RNA 
extractions, from the same biological sample, randomly selected from our pool of biofilms. Table 
2.4 represents the gene expression found, originated from independent RNA extractions within the 
same biological sample, therefore eliminating the biological variability. 
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Table 2.4 – Quantification of gene expression normalized to 16S, using four different RNA extractions from the same 
biofilm. 
Sample aap lrgB fmtC icaA pgi 
 
RNA 1 
2,32E-04 5,91E-05 1,28E-04 2,04E-04 8,46E-04 
2,96E-04 5,54E-05 1,20E-04 2,15E-04 1,08E-03 
3,18E-04 6,59E-05 1,24E-04 1,82E-04 8,76E-04 
 
RNA 2 
3,17E-04 4,59E-05 8,39E-05 1,80E-04 2,33E-04 
2,85E-04 4,62E-05 8,33E-05 1,98E-04 3,23E-04 
3,01E-04 4,27E-05 6,59E-05 1,68E-04 5,16E-04 
 
RNA 3 
4,91E-04 6,97E-05 1,06E-04 2,44E-04 8,54E-04 
4,98E-04 7,11E-05 1,01E-04 2,02E-04 7,85E-04 
4,66E-04 5,55E-05 8,29E-05 2,27E-04 5,98E-04 
 
RNA 4 
4,47E-04 7,26E-05 8,58E-05 2,29E-04 7,79E-04 
4,47E-04 6,22E-05 7,91E-05 2,27E-04 5,61E-04 
4,78E-04 5,82E-05 8,52E-05 2,35E-04 5,24E-04 
 
 
Not surprisingly, without the biological variability into account, the coefficient of variability 
observed was smaller, ranging from 12 % (icaA) to 37 % (pgi), as can be seen in Figure 2.4. The 
overall gene expression variability was 23 % ± 9.7 %.  
In literature, this step is known to influenciate gene expression (França et al., 2012 and 
Sieber et al., 2010). In this study, the variability was not significant for majority of the genes. 
However, pgi gene had a considerable variability.  
 
Figure 2.4 - Coefficient of RNA extraction variability (in %) of gene expression of aap, lrgB, fmtC, icaA, pgi. 
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Sieber et al. (2010), was among the first to address the importance of that transcription 
reverse procedure in stable gene expression. They determined that gene expression reliability 
would not be achievable if using low concentrations of starting RNA. However, the intrinsic strength 
of the process was not determined. After assessing the variability associated with different RNA 
extractions, we proceeded with cDNA synthesis variability. To achieve that, we performed four 
independent cDNA synthesis from the same RNA sample, that was randomly selected from pool of 
samples. Table 2.5 represents gene expression determination from different cDNA obtained from 
the same RNA sample. 
Interestingly, the overall gene expression variability, as determined by the average of each 
gene variability, was 24 % ± 4.8 %, not much different from the overall gene expression variability 
observed in the previous experimental step. 
Table 2.5 – Quantification of gene expression normalized to 16S, using four cDNA synthesis obtained from the same 
RNA sample. 
Sample aap lrgB fmtC icaA pgi 
 
cDNA 1 
2,32E-04 3,92E-05 8,81E-05 2,04E-04 8,46E-04 
2,96E-04 3,67E-05 8,24E-05 2,15E-04 1,08E-03 
3,18E-04 4,39E-05 8,52E-05 1,82E-04 8,76E-04 
 
cDNA 2 
4,80E-04 6,52E-05 1,73E-04 2,12E-04 7,77E-04 
4,90E-04 6,60E-05 1,81E-04 2,30E-04 8,35E-04 
5,43E-04 7,10E-05 1,41E-04 2,42E-04 7,76E-04 
 
cDNA 3 
4,75E-04 7,46E-05 1,58E-04 2,32E-04 5,16E-04 
4,47E-04 5,82E-05 1,51E-04 2,78E-04 2,07E-04 
5,27E-04 5,76E-05 1,28E-04 1,49E-04 5,38E-04 
 
cDNA 4 
5,89E-04 6,99E-05 1,57E-04 1,91E-04 7,85E-04 
6,06E-04 8,06E-05 1,21E-04 2,69E-04 7,06E-04 
5,38E-04 5,71E-05 1,43E-04 2,61E-04 7,65E-04 
 
The variability was similar between all genes. Although, the gene that presented more 
variability was pgi (30 %) and icaA (17 %) with less variability (Figure 2.5). In cDNA synthesis, no 
discrepancies of expression were seen between different genes. 
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Figure 2.5 - Coefficient of reverse transcriptase variability (in %) of gene expression of aap, lrgB, fmtC, icaA, pgi. 
 
 After determining the gene expression variability from the experimental processes required 
to obtain and prepare the sample, we then had to quantify the variability of the quantification step 
of the experiment: the qPCR run. Of note, since this step was always present, in the previous 
experiments, this last experimental set-up could be considered as the blank of the experiment.  We 
randomly selected one cDNA sample and performed four independent qPCR runs. The results of 
this experiment are represented in Table 2.6. 
Table 2.6 – Quantification of gene expression normalized to 16S, in four qPCR experiences from the same cDNA. 
Sample aap lrgB fmtC icaA pgi 
 
qPCR 1 
3,18E-04 7,68E-05 5,03E-05 1,90E-04 1,00E-03 
3,18E-04 6,62E-05 4,63E-05 2,29E-04 1,28E-03 
3,40E-04 6,21E-05 4,99E-05 2,03E-04 1,04E-03 
 
qPCR 2 
2,54E-04 5,47E-05 4,24E-05 1,92E-04 1,35E-03 
2,58E-04 5,28E-05 4,81E-05 2,32E-04 1,32E-03 
2,72E-04 5,56E-05 5,31E-05 1,78E-04 9,64E-04 
 
qPCR 3 
2,24E-04 6,13E-05 5,51E-05 2,44E-04 1,46E-03 
2,97E-04 5,73E-05 6,36E-05 2,57E-04 1,29E-03 
2,85E-04 5,53E-05 5,74E-05 2,17E-04 7,23E-04 
 
qPCR 4 
3,34E-04 5,89E-05 5,81E-05 2,16E-04 8,60E-04 
3,17E-04 4,45E-05 5,73E-05 1,65E-04 1,47E-03 
2,53E-04 4,65E-05 5,72E-05 1,79E-04 1,48E-03 
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Not surprisingly, the overall gene expression variability, as determined by the average of 
each gene variability, was the lowest of all the experimental steps: 15 % ± 4.1 %. The gene that 
presented more variability was pgi (22 %) and fmtC (11 %) with less variability (Figure 2.6).  
 
Figure 2.6 - Coefficient of qPCR variability (in %) of gene expression of aap, lrgB, fmtC, icaA, pgi. 
 
 Overall, our study suggests that the observed variability in S. epidermidis biofilm gene 
expression studies is mainly the result of the biologic variability obtained in this complex microbial 
community.  
 A major limitation of our study was the use of only five genes. In order to be as 
representative as possible, we selected genes locate in different positions of the genome and also 
with distinct functions. Furthermore, since the samples were randomly selected for each 
experimental step, we can’t guarantee that a different selection would result in the same outcome. 
Ideally, this process should be repeated for each of the samples used. However, due to the costs 
associated, this was not possible to perform. 
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3.1 Introduction 
 Gene expression studies are an important analysis tool since it allows evaluating and 
understanding the influence of the genes and respective functions in biofilm formation. This confers 
virulence to S. epidermidis strains and consequently, the incidence of persistent infections (factor 
(O´Gara and Humphreys, 2001). As well known, biofilm formation depends on some conditions, 
namely the strains used, growth medium and hydrodinamic conditions (Cerca, N., 2006). 
Regarding to S. epidermidis strains is known that different strains of the same species can be 
phenotypically and genetically different (Cerca, N., 2006). In this chapter, it will be discussed 
biofilm formation between some S. epidermidis strains and the presence of genes of interest in this 
study (aap, icaA, fmtC, lrgB and pgi).  
The main objective of the work described in this chapter was to reduce the coefficient of 
biologic variability in gene expression which presented the majority of variability as discussed in 
Chapter 2, in S. epidermidis biofilms. To achieve that, we proposed an experimental protocol that 
we hypothesized allow us to diminish the variability from a pool of 20 biofilms (Figure 3.1).  
 
                                                   
Figure 3.1 - Scheme representation of a proposed experimental protocol aiming to reduce the coefficient of gene 
expression variability. 
 
3.2 Material and Methods 
 
3.2.1 Bacterial strain and growth conditions  
 The bacterial strain and growth conditions were performed as described in previous 
chapter but the strains used were S. epidermidis RP62A (PubMed accession number: 
PRJNA57663, ID: 57663), S. epidermidis 9142 (Mack et al., 1994), S. epidermidis M129 (Cerca, 
N., 2006), S. epidermidis FJ6 (Cerca, N., 2006), S. epidermidis JI6 (Cerca, N., 2006), S. 
epidermidis LE7 (Cerca, N., 2006), S. epidermidis IE186 (Cerca, N., 2006) and S. epidermidis 
1457 (Mack et al., 1992).  
Biofilm growth 
Pool 20 biofilms 
RNA extraction cDNA  synthesis qPCR 
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3.2.2.1 Biofilm formation disruption 
 After the respective incubation time and the washing with saline solution, each biofilm was 
resuspended in 1 mL of 0,9 % (w/v) Sodium Chloride (NaCl) and dislodged by scraping followed by 
sonication (Cole-Parmer® 750-Watt Ultrasonic Homogenizer, 230 VAC, using a 13 mm microtip) 
using one cycle: 10 seconds at 30 % of amplitude (3 times each). The 1.5 mL eppendorf tubes 
(Bioplastics, Frilabo) were kept on ice during sonication (Freitas et al., 2013). 
 
3.2.3 Genomic DNA Extraction and PCR 
 The protocol described here consists in DNA extraction based on thermal shock 
(Henriques, A. et al., 2012). Briefly, it consists in 100 µL of ultrapure water plus 10 µL of vial 
suspension. Then, the samples are incubated 10 min at 100ºC, in a thermal block (Alfagene) 
followed by 5 min on ice. After that, centrifuged at maximum speed 10 min at 4ºC. The suspension 
was removed for a new 1.5 mL eppendorf tubes. For PCR, the mix to each sample are composed 
by 5 µL of dymezyme (Thermo Scientific, Frilabo), 3 µL of water, 1 µL of primer set and 1 µL of 
sample. PCR amplifications were performed using thermal cycler (MJ MiniTM Personal Thermal 
Cycler, Bio-rad). The following cycle for thermal cycle were 94ºC during 2 minutes, 94ºC during 30 
seconds, 58ºC during 20 seconds, 72ºC during 20 seconds, 72ºC during 5 minutes and 4ºC 
forever. 35 cycles were performed between 94ºC (30 seconds) to 72ºC (5 minutes). DNA samples 
were analyzed in 1.5 % agarose gel stained with Midori Green DNA (Nippon Genetics Europe 
GmbH, Germany) at 80 V. DNA samples in the presence of genes of interest have one band with 
respective size per gene. 
 
3.3 Optimized quantification of gene expression  
Gene expression quantification was performed as described in the previous chapter, with a 
minor modification. Here, a pool of 20 biofilms was resuspended in each 1.5 mL DNase/RNase 
free tubes, and from each tube two independent RNA extractions were performed. 
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3.4 Results and Discussion  
 To validate our findings in a clinical setting, we first started to determine the biofilm 
formation ability using different S. epidermidis strains, selected from a group of commensal and 
pathogenic isolates (Table 3.1). As expected, we found a high variability of biofilm formation 
amongst the strains used (Figure 3.2). Comparing all strains used, the clinical isolate (RP62A) 
formed more biofilm while the commensal isolate (FJ6) less biofilm, in 24 H. 
Table 3.1 - Origin of different S. epidermidis strains. 
Strain Origin of strain 
RP62A ATCC 
9142 Biofilm positive control - clinical isolate (Mack et al., 1994) 
M129 Isolated from dialysis-associated peritonitis patients  
(Cerca, N., 2006) 
IE186 Isolated from infective endocarditis patients (Cerca, N., 2006) 
1457 Isolated from central venous catheter-associated infection (Mack et al., 
1992) 
FJ6  
Strains isolated from the skin (Cerca, N., 2006) JI6 
LE7 
 
 
 
Figure 3.2 - Biofilm formation, at 24 H, was quantified by a spectrophotometry (640 nm filter): ATCC strain at blue 
color, clinical strains at red color and commensal strains at green color. 
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After determining the biofilm formation ability, we then wanted to know if the selected 
strains had the presence of the genes tested in the previous chapter (aap, lrgB, fmtC, icaA and 
pgi). As can be shown in Table 3.2, most S. epidermidis had all the five genes but some lacked 
either aap, icaA or pgi. Taking in account the capacity of biofilm formation, we decided to include 
strain 9142 in the gene expression studies. 
Table 3.2 – Presence of genes of interest by PCR by two independent primer sets. 
Strains  
aap 
    Genes 
lrgB 
 
fmtC 
 
icaA 
 
pgi 
RP62A + + + + + 
9142 + + + + + 
M129 + + + - + 
IE186 + + + + - 
1457 + + + + - 
FJ6 + + + + + 
JI6 + + + + + 
LE7 - + + + + 
+, presence of gene; -, absence of gene or primer dimer. 
 
Since biological replicates had more variability, compared with other steps (discussed in 
Chapter 2), we decided to pool 20 biofilms, in order to diminish the biological variability coefficient. 
We tested two of the five genes: aap, which presented medium coefficient of gene expression 
variation and pgi wich presented an higher coefficient of gene expression variation. The comparison 
results between biological replicates (Chapter 2) and two optimization assays (two replicates of 
each) of the aap gene can be observed in Figure 3.3 and pgi gene in Figure 3.4.  
Based on our results, we can observe that our strategy of pooling 20 biofilms, resulted in a 
reduction of the coefficient of aap expression variation from 54 % to 18 % (Figure 3.3). Interestingly, 
the same was observed for the expression of pgi gene (reduction from 87 % to 34 %) (Figure 3.4). 
In order to confirm that our findings were valid on clinical isolates, at the same time 
confirming that they were strain independent, we repeated the same experience using strain 9142. 
As can be seen in Figure 3.5 (aap) and Figure 3.6 (pgi), our strategy allowed a reduction of the 
coefficient of gene expression variation from 94 % to 34 % (aap) and from 84 % to 43 % (pgi).  
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Figure 3.3 - Comparison of biologic variability coefficient, in aap gene, without and with a pool of 20 biofilms (RP62A 
strain). 
 
Figure 3.4 - Comparison of biologic variability coefficient, in pgi gene, without and with a pool of 20 biofilms (RP62A 
strain). 
 
54% of coefficient of variability 18% of coefficient of variability 
  87%of  coefficient of variability 
34% of coefficient of variability 
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Figure 3.5 - Comparison of biologic variability coefficient, in aap gene, without and with a pool of 20 biofilms (9142 
strain). 
 
 
Figure 3.6 - Comparison of biologic variability coefficient, in pgi gene, without and with a pool of 20 biofilms (9142 
strain). 
 
Overall, our results confirmed that the strategy of pooling 20 biofilms in each RNA 
extraction, successfully reduced the biological variability in gene expression studies of S. 
94 % of coefficient of variability 
34 % of coefficient of variability 
84 % of coefficient of variability 
43 % of coefficient of variability 
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epidermidis biofilms. An interesting question that was not answered was the minimum number of 
biofilms to be pooling, in order to achieve this reduction in variability. On the other hand, we did not 
explore if by using a higher number of biofilms, per pool, would further reduced the biological 
variability. Nevertheless, the principle of pooling the biofilms as a strategy of reducing the variability 
of the gene expression studies was demonstrated. These results provide an important insight for 
researchers working with gene expression in biofilms, since our strategy will allow more 
reproducible and accurate results. 
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 As described throughout this thesis, S. epidermidis is a commensal habitant of human skin 
but the biofilms formed by this species are responsible for many infections in indwelling medical 
devices. To better understand how biofilms enhance S. epidermidis virulence, it is important to 
perform gene expression studies with biofilms. However, due to the complex nature of biofilms, 
RNA extraction can, sometimes, be a problem. One phenomena observed has to do with the high 
variability of gene expression in biofilms but the origin of this variability was unknown. Therefore, in 
order to demonstrate and understand the variability of gene expression quantification, we aimed to 
study the individual experimental steps, namely bacterial growth, RNA extraction, reverse 
transcriptase reaction and real-time quantitative PCR and its impact on the gene expression 
variability. 
 In response to the principal aim of this work, our results revealed that bacterial growth 
presented more variability, although this percentage differs between genes. The others 
experimental steps did not revealed a significant variability for the majority of the genes of interest. 
 Additionally, we proposed an optimized protocol to minimize the variability inherent to 
biological step and to enhance gene expression reproducibility. We demonstrated that is possible 
minimize this variability using a pool of 20 biofilms in a single RNA extraction.  
 A limitation of our study was the use of few genes and strains. In future works, it would be 
necessary increase the number of strains and test all experimental steps, since we only performed 
all the tests in RP62A, mainly due the costs associated. Furthermore, the increase of genes could 
be interesting and clearly, more assays allow comparing the results with a higher deepness. Finally, 
it would also be interesting to test different quantity of biofilm pools, in order to demonstrate the 
minimum biofilm pool that may reduce, substantially, the variability. By following this approach, it 
would be possible to maintain gene expression quantification with more specificity and authenticity. 
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